003090 Stock Chart & Stats
₩16630.00
-₩340.00(-2.00%)
―
--
Day’s Range― - ―
52-Week Range₩15,650.00 - ₩30,600.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)66.00K
Market Cap
₩693.92B
Enterprise ValueN/A
Total Cash (Recent Filing)₩301.49B
Total Debt (Recent Filing)₩948.45B
Price to Earnings (P/E)3.5
Beta0.45
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4786.33
Shares Outstanding58,141,980
10 Day Avg. Volume66,142
30 Day Avg. Volume65,996
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.09
Price to Sales (P/S)0.62
P/FCF Ratio-34.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)5,725,403.82
Revenue Forecast (FY)₩10.00T>
003090 FAQ
What was Daewoong Co., Ltd.’s price range in the past 12 months?
Daewoong Co., Ltd. lowest stock price was ₩15650.00 and its highest was ₩30600.00 in the past 12 months.
What is Daewoong Co., Ltd.’s market cap?
Daewoong Co., Ltd.’s market cap is ₩693.92B.
When is Daewoong Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Daewoong Co., Ltd.’s earnings last quarter?
Daewoong Co., Ltd. released its earnings results on May 15, 2026. The company reported ₩838.759 earnings per share for the quarter, beating the consensus estimate of N/A by ₩838.759.
Is Daewoong Co., Ltd. overvalued?
According to Wall Street analysts Daewoong Co., Ltd.’s price is currently Undervalued.
Does Daewoong Co., Ltd. pay dividends?
Daewoong Co., Ltd. does not currently pay dividends.
What is Daewoong Co., Ltd.’s EPS estimate?
Daewoong Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Daewoong Co., Ltd. have?
Daewoong Co., Ltd. has 58,141,980 shares outstanding.
What happened to Daewoong Co., Ltd.’s price movement after its last earnings report?
Daewoong Co., Ltd. reported an EPS of ₩838.759 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.315%.
Which hedge fund is a major shareholder of Daewoong Co., Ltd.?
Currently, no hedge funds are holding shares in KR:003090
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Daewoong Co., Ltd.
Operating alongside its various subsidiaries, Daewoong Co., Ltd. is primarily engaged in the production and sale of pharmaceutical products. Additionally, the company generates income from real estate leasing. Established in 1961, the firm transitioned its name from Daewoong Pharmaceutical Co., Ltd. to its current designation, Daewoong Co., Ltd., in 2002. Its corporate headquarters are located in Seongnam-si, South Korea.
JW Pharmaceutical Corporation
―
Pharmicell Co., Ltd
―
Komipharm International Co., Ltd
―
DongKook Pharmaceutical Co., Ltd.
―
SK Chemicals Co., Ltd.
―